BL
LLY icon

Balentine LLC’s Eli Lilly LLY Stock Holding History

Balentine LLC’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.77M Sell
4,101
-198
-5% -$201K 0.15% 34
2025
Q4 		$4.62M Buy
4,299
+257
+6% +$246K 0.18% 32
2025
Q3 		$3.08M Buy
4,042
+2,426
+150% +$1.81M 0.11% 40
2025
Q2 		$1.26M Buy
1,616
+349
+28% +$271K 0.05% 61
2025
Q1 		$1.05M Hold
1,267
– – 0.04% 69
2024
Q4 		$978K Sell
1,267
-62
-5% -$51.3K 0.04% 58
2024
Q3 		$1.18M Buy
1,329
+84
+7% +$75.5K 0.05% 60
2024
Q2 		$1.13M Sell
1,245
-29,170
-96% -$23.3M 0.05% 52
2024
Q1 		$23.7M Sell
30,415
-305
-1% -$217K 0.71% 16
2023
Q4 		$17.9M Buy
30,720
+3,293
+12% +$1.92M 0.57% 18
2023
Q3 		$14.7M Buy
27,427
+273
+1% +$141K 0.49% 18
2023
Q2 		$12.7M Buy
27,154
+1,849
+7% +$775K 0.42% 19
2023
Q1 		$8.69M Sell
25,305
-3,106
-11% -$1.05M 0.29% 30
2022
Q4 		$10.4M Buy
28,411
+1,588
+6% +$563K 0.36% 27
2022
Q3 		$8.67M Sell
26,823
-15,132
-36% -$4.79M 0.33% 22
2022
Q2 		$13.6M Buy
41,955
+34,075
+432% +$10.2M 0.5% 23
2022
Q1 		$2.26M Buy
7,880
+2,473
+46% +$636K 0.08% 74
2021
Q4 		$1.49M Buy
5,407
+3,077
+132% +$780K 0.05% 63
2021
Q3 		$538K Buy
2,330
+210
+10% +$51.8K 0.02% 110
2021
Q2 		$487K Buy
2,120
+317
+18% +$63.7K 0.02% 85
2021
Q1 		$337K Buy
1,803
+198
+12% +$38.7K 0.01% 96
2020
Q4 		$271K Buy
1,605
+86
+6% +$12.8K 0.01% 108
2020
Q3 		$225K Buy
1,519
+180
+13% +$27.9K 0.01% 109
2020
Q2 		$220K Sell
1,339
-49
-4% -$7.52K 0.01% 89
2020
Q1 		$193K Buy
1,388
+366
+36% +$50.3K 0.01% 67
2019
Q4 		$134K Buy
1,022
+844
+474% +$97.8K 0.01% 95
2019
Q3 		$20K Buy
178
+72
+68% +$8.02K ﹤0.01% 234
2019
Q2 		$12K Buy
+106
New +$12.5K ﹤0.01% 282
2019
Q1 		– Sell
-53
Closed -$6K – 452
2018
Q4 		$6K Buy
+53
New +$5.92K ﹤0.01% 339
2018
Q3 		– Sell
-333
Closed -$28K – 379
2018
Q2 		$28K Buy
+333
New +$27.4K ﹤0.01% 45
2018
Q1 		– Sell
-3,017
Closed -$255K – 320
2017
Q4 		$255K Sell
3,017
-30
-1% -$2.55K 0.02% 99
2017
Q3 		$261K Buy
3,047
+2,274
+294% +$187K 0.02% 94
2017
Q2 		$64K Buy
773
+313
+68% +$25.5K 0.01% 214
2017
Q1 		$39K Buy
460
+250
+119% +$20K ﹤0.01% 261
2016
Q4 		$15K Buy
210
+20
+11% +$1.49K ﹤0.01% 361
2016
Q3 		$15K Buy
190
+20
+12% +$1.6K ﹤0.01% 302
2016
Q2 		$13K Hold
170
– – ﹤0.01% 304
2016
Q1 		$12K Sell
170
-383
-69% -$29K ﹤0.01% 237
2015
Q4 		$47K Buy
553
+6
+1% +$498 0.01% 160
2015
Q3 		$46K Buy
547
+447
+447% +$37.7K 0.01% 180
2015
Q2 		$8K Hold
100
– – ﹤0.01% 335
2015
Q1 		$7K Buy
+100
New +$7.12K ﹤0.01% 306

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Balentine LLC's LLY Position: Q1 2026 in Review

Balentine LLC reduced its Eli Lilly (LLY) stake by 4.6% in Q1 2026, selling an estimated $201K and leaving 4,101 shares worth $3.77M. The position accounts for 0.15% of the portfolio, ranked #34.

Balentine LLC first reported a position in LLY in Q1 2015 and has held it in 42 quarters since. The position peaked at $23.7M in Q1 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Balentine LLC held 4,101 shares of Eli Lilly worth $3.77M as of Q1 2026.
  • Balentine LLC sold 198 Eli Lilly shares in Q1 2026, an estimated $201K.
  • Eli Lilly made up 0.15% of Balentine LLC's portfolio in Q1 2026, its #34 holding.
  • Balentine LLC first reported a position in Eli Lilly in Q1 2015 and has held it in 42 quarters since.
  • Balentine LLC's Eli Lilly position peaked at $23.7M in Q1 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Balentine LLC's 13F filing for Q1 2026, filed 24 Apr 2026.